• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成瘾性疾病治疗中的持续护理。

Continuing care in the treatment of addictive disorders.

作者信息

McKay James R

机构信息

University of Pennsylvania, Treatment Research Center, 3900 Chestnut Street, Philadelphia, PA 19104, USA.

出版信息

Curr Psychiatry Rep. 2006 Oct;8(5):355-62. doi: 10.1007/s11920-006-0036-9.

DOI:10.1007/s11920-006-0036-9
PMID:16968615
Abstract

Newer models of continuing care in the addictions are designed to improve the long-term management of substance use disorders by engaging patients into flexible, or "adaptive," treatment algorithms that change in focus and intensity as symptoms wax and wane over time. This article describes some of these newer approaches to the management of substance use disorders and presents recent research on their effectiveness. Findings suggest the following: 1) Continuing care interventions of a year or longer are more likely to show significant positive effects; 2) Continuing care treatments that are less burdensome to patients appear to promote higher rates of sustained engagement; 3) More structured and intensive continuing care may be more effective for patients with severe substance dependence and associated problems and for those who fail to achieve reasonable progress while in the initial phase of treatment; and 4) Use of medications as part of continuing care is increasing.

摘要

成瘾领域中新型的持续护理模式旨在通过让患者参与灵活的或“适应性”治疗算法来改善物质使用障碍的长期管理,这些算法会随着症状随时间的起伏而在重点和强度上发生变化。本文描述了一些管理物质使用障碍的新型方法,并介绍了关于其有效性的最新研究。研究结果表明:1)持续一年或更长时间的护理干预更有可能显示出显著的积极效果;2)对患者负担较小的持续护理治疗似乎能促进更高的持续参与率;3)对于有严重物质依赖及相关问题的患者以及在治疗初始阶段未能取得合理进展的患者,更结构化、更强化的持续护理可能更有效;4)作为持续护理一部分使用药物的情况正在增加。

相似文献

1
Continuing care in the treatment of addictive disorders.成瘾性疾病治疗中的持续护理。
Curr Psychiatry Rep. 2006 Oct;8(5):355-62. doi: 10.1007/s11920-006-0036-9.
2
The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes.基于电话的酒精和可卡因依赖持续护理的有效性:24个月的结果。
Arch Gen Psychiatry. 2005 Feb;62(2):199-207. doi: 10.1001/archpsyc.62.2.199.
3
Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy.用纳曲酮和预防复发疗法治疗可卡因-酒精依赖
Am J Addict. 2004 Jul-Sep;13(4):333-41. doi: 10.1080/10550490490480982.
4
Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review.用于酒精依赖药物治疗的阿片类拮抗剂——一项批判性综述。
Curr Drug Abuse Rev. 2008 Nov;1(3):280-91. doi: 10.2174/1874473710801030280.
5
Treating alcoholism as a chronic disease: approaches to long-term continuing care.将酒精成瘾视为一种慢性病:长期持续护理的方法。
Alcohol Res Health. 2011;33(4):356-70.
6
Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study.酒精依赖患者对安慰剂有反应吗?联合研究的结果。
J Stud Alcohol Drugs. 2008 Nov;69(6):878-84. doi: 10.15288/jsad.2008.69.878.
7
Predictors of dropout in an outpatient treatment for problem drinkers including cognitive-behavioral therapy and the opioid antagonist naltrexone.问题饮酒者门诊治疗中包括认知行为疗法和阿片类拮抗剂纳曲酮在内的退出治疗的预测因素。
J Stud Alcohol Drugs. 2013 Nov;74(6):894-901. doi: 10.15288/jsad.2013.74.894.
8
Current strategies for the treatment of alcohol dependence in the United States.美国目前治疗酒精依赖的策略。
Drug Alcohol Depend. 1995 Sep;39 Suppl 1:S3-7. doi: 10.1016/0376-8716(95)01167-w.
9
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.酒精依赖的联合药物治疗与行为干预:综合疗法研究:一项随机对照试验
JAMA. 2006 May 3;295(17):2003-17. doi: 10.1001/jama.295.17.2003.
10
New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.澳大利亚新的酒精问题治疗指南:推荐意见概述。
Med J Aust. 2021 Oct 4;215 Suppl 7:S3-S32. doi: 10.5694/mja2.51254.

引用本文的文献

1
Alcohol Use Disorder and Antisocial and Borderline Personality Disorders.酒精使用障碍与反社会型和边缘型人格障碍
Alcohol Res. 2019 Dec 30;40(1). doi: 10.35946/arcr.v40.1.05. eCollection 2019.
2
Testing mediational processes of substance use relapse among youth who participated in a mobile texting aftercare project.测试参与手机短信随访项目的青少年物质使用复发的中介过程。
Subst Abus. 2022;43(1):1-12. doi: 10.1080/08897077.2019.1671941. Epub 2019 Oct 22.
3
Critical Transitions: A Mixed Methods Examination of Sleep from Inpatient Alcohol Rehabilitation Treatment to the Community.

本文引用的文献

1
An experimental evaluation of recovery management checkups (RMC) for people with chronic substance use disorders.针对患有慢性物质使用障碍者的康复管理检查(RMC)的实验性评估。
Eval Program Plann. 2003 Aug;26(3):339-352. doi: 10.1016/S0149-7189(03)00037-5.
2
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.对于抑郁症患者,在选择性5-羟色胺再摄取抑制剂(SSRI)治疗失败后使用安非他酮缓释片、舍曲林或文拉法辛缓释片。
N Engl J Med. 2006 Mar 23;354(12):1231-42. doi: 10.1056/NEJMoa052963.
3
Continuity of care practices and substance use disorder patients' engagement in continuing care.
关键转变:从住院酒精康复治疗到社区的睡眠混合方法研究。
PLoS One. 2016 Aug 29;11(8):e0161725. doi: 10.1371/journal.pone.0161725. eCollection 2016.
4
Youth recovery outcomes at 6 and 9 months following participation in a mobile texting recovery support aftercare pilot study.参与一项移动短信康复支持后续试点研究后6个月和9个月时的青少年康复结果。
Am J Addict. 2016 Jan;25(1):62-8. doi: 10.1111/ajad.12322. Epub 2015 Dec 21.
5
Toward cost-effective staffing mixes for Veterans Affairs substance use disorder treatment programs.寻求退伍军人事务部物质使用障碍治疗项目具有成本效益的人员配置组合。
BMC Health Serv Res. 2015 Nov 23;15:515. doi: 10.1186/s12913-015-1175-7.
6
The Key to Individualized Addiction Treatment is Comprehensive Assessment and Monitoring of Symptoms and Behavioral Change.个性化成瘾治疗的关键在于对症状及行为变化进行全面评估和监测。
Behav Sci (Basel). 2015 Oct 30;5(4):477-95. doi: 10.3390/bs5040477.
7
Maintenance Check-ups Following Treatment for Cannabis Dependence.大麻依赖治疗后的维持检查
J Subst Abuse Treat. 2015 Sep;56:11-5. doi: 10.1016/j.jsat.2015.03.006. Epub 2015 Apr 11.
8
Medications for unhealthy alcohol use: across the spectrum.针对不健康饮酒的药物:涵盖整个范围。
Alcohol Res Health. 2011;33(4):300-12.
9
Ten take home lessons from the first 10 years of the CTN and 10 recommendations for the future.从 CTN 的头 10 年中吸取 10 点经验教训,并为未来提出 10 点建议。
Am J Drug Alcohol Abuse. 2011 Sep;37(5):275-82. doi: 10.3109/00952990.2011.596978.
10
Initiation and engagement in chronic disease management care for substance dependence.启动并参与慢性疾病管理治疗物质依赖。
Drug Alcohol Depend. 2011 May 1;115(1-2):80-6. doi: 10.1016/j.drugalcdep.2010.10.013. Epub 2010 Dec 18.
连续性照护实践与物质使用障碍患者对持续照护的参与度
Med Care. 2005 Dec;43(12):1234-41. doi: 10.1097/01.mlr.0000185736.45129.95.
4
Is there a case for extended interventions for alcohol and drug use disorders?对于酒精和药物使用障碍,是否有必要进行长期干预?
Addiction. 2005 Nov;100(11):1594-610. doi: 10.1111/j.1360-0443.2005.01208.x.
5
A randomised trial of early warning signs relapse prevention training in the treatment of alcohol dependence.一项关于早期预警信号复发预防训练治疗酒精依赖的随机试验。
Addict Behav. 2005 Jul;30(6):1111-24. doi: 10.1016/j.addbeh.2004.10.008. Epub 2004 Nov 10.
6
Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial.长效注射用纳曲酮治疗酒精依赖的疗效及耐受性:一项随机对照试验
JAMA. 2005 Apr 6;293(13):1617-25. doi: 10.1001/jama.293.13.1617.
7
Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring.重新审视成瘾治疗评估:从回顾性随访到同步康复监测。
Addiction. 2005 Apr;100(4):447-58. doi: 10.1111/j.1360-0443.2005.01012.x.
8
Factors associated with treatment outcomes in an aftercare population.
Am J Addict. 2004 Oct-Dec;13(5):447-60. doi: 10.1080/10550490490512780.
9
The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes.基于电话的酒精和可卡因依赖持续护理的有效性:24个月的结果。
Arch Gen Psychiatry. 2005 Feb;62(2):199-207. doi: 10.1001/archpsyc.62.2.199.
10
The effectiveness of telephone-based continuing care in the clinical management of alcohol and cocaine use disorders: 12-month outcomes.基于电话的持续护理在酒精和可卡因使用障碍临床管理中的有效性:12个月的结果。
J Consult Clin Psychol. 2004 Dec;72(6):967-79. doi: 10.1037/0022-006X.72.6.967.